Enhancement by misonidazole of metastatic tumor nodule formation in the lungs of mice.
Investigations were performed to determine whether misonidazole, a hypoxic cell radiosensitizer, influences formation of tumor nodules in the lung of C3Hf/Kam mice and whether it affects the enhancement of tumor nodule formation caused by local thoracic irradiation (LTI). Cells from a chemically-induced fibrosarcoma (FSa) and a spontaneously-developed fibrosarcoma (NFSa) formed twice as many tumor colonies in the lungs of mice that received misonidazole as in untreated mice. The effect was observed only with doses of misonidazole of 1 mg/g or higher given within 2 days prior to i.v. injection of tumor cells. A similar twofold amplification of the effect of LTI occurred when 1 mg/g misonidazole was given 30 min before or 0.5 to 2 hours after irradiation. This increase was independent of the dose of LTI and the absolute number of tumor nodules in the lung. The mechanistic possibilities and clinical relevance of the misonidazole effect are discussed.
D000818:Animals; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005354:Fibrosarcoma / Q000556:secondary*; D005720:Gamma Rays; D008168:Lung / Q000187:drug effects* / Q000473:pathology / Q000528:radiation effects; D008175:Lung Neoplasms / Q000556:secondary*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008920:Misonidazole / Q000494:pharmacology*; D012513:Sarcoma, Experimental / Q000556:secondary*
D008920:Misonidazole